ORIGINAL RESEARCH article

Front. Microbiomes

Sec. Host and Microbe Associations

Volume 4 - 2025 | doi: 10.3389/frmbi.2025.1543144

This article is part of the Research TopicThe Microbiome in Cancer Therapy ResponseView all 5 articles

Obesity Reprograms the Normal Pancreas and Pancreatic Cancer Microbiome in Mice and Humans

Provisionally accepted
Raquel  Santana da CruzRaquel Santana da Cruz1Shravanthy  SuguruShravanthy Suguru1Sara  PC PaivaSara PC Paiva1Ijeoma  NwugwoIjeoma Nwugwo1Bashkar  KallakuryBashkar Kallakury1Benjamin  Adam WeinbergBenjamin Adam Weinberg1Katherine  L CookKatherine L Cook2Sonia  de AssisSonia de Assis1*
  • 1Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, D.C., United States
  • 2Department of Cancer Biology, School of Medicine, Wake Forest University, Winston-Salem, North Carolina, United States

The final, formatted version of the article will be published soon.

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive form of pancreatic cancer, with overall 5-year survival rates of about 8%. Obesity (and underlying metabolic dysfunction) is estimated to account for up to 50% of all PDACs. Microbial communities can be modulated by obesity and exert biological effects on tissues they colonize as well as distant sites. Recent studies showed that tumors, including PDAC, harbor a microbiome that is able to regulate cancer outcomes such as tumor progression, response to therapy and overall survival. Yet, it is not understood whether patient’s characteristics impact this relationship. Here, we examined the influence of obesity (defined by body weight in mice or body mass index [BMI] in humans) on the normal and cancerous pancreas microbiome in mice and humans using 16S sequencing. Overall, we observed that diet-induced obesity accelerated PDAC progression in the KC mouse model of PDAC. We also detected an obesity-induced decrease in the microbial abundance of the normal or cancerous pancreas. Obesity modified the bacterial community composition in the normal pancreas and PDAC of both mice and humans. Further, obese animals and humans each had a distinctive pancreatic microbiome signature with specific bacterial phylum, genus and species compared to controls. Notably, both the normal mouse pancreas and human PDAC showed an obesity-induced decrease in Proteobacteria phylum. We also found that the presence of cancer by itself reduced microbial diversity in both the pancreas as well the intestinal microbiota. This reduction in microbial richness was further exacerbated by obesity. Finally, we observed that obesity increased inflammatory cytokines and altered the tumor immune infiltrate in humans and mice.

Keywords: PDAC, Pancreatic Ductal Adenocarcinoma, Obesity, microbiome, Mouse, human

Received: 10 Dec 2024; Accepted: 24 Jun 2025.

Copyright: © 2025 da Cruz, Suguru, Paiva, Nwugwo, Kallakury, Weinberg, Cook and de Assis. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Sonia de Assis, Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, D.C., United States

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.